Key result
MIS-C linked to elevated cytokine-expressing T cells vs uncomplicated COVID-19, resolving by 9 months.
Why the study?
T-cell responses in children with multisystem inflammatory syndrome (MIS) following COVID-19 have not been well-studied.
Does SARS-CoV-2 antigen stimulation induce higher T-cell cytokine expression in children with MIS-C compared to acute COVID-19 and other infections?
Observational (n=35)
Single-blind
Yes
Does SARS-CoV-2 antigen stimulation induce higher T-cell cytokine expression in children with MIS-C compared to acute COVID-19 and other infections?
MIS-C is characterized by enhanced SARS-CoV-2 antigen-specific CD4+ and CD8+ T-cell responses that down-modulate upon recovery, suggesting a hyperinflammatory cellular immune mechanism.
May support hyperinflammatory T-cell mechanism in MIS-C; hypothesis-generating and should not yet change practice.
Background Multisystem inflammatory syndrome (MIS) in children is considered to be a post-infectious complication of COVID-19. T-cell responses in children with this condition have not been well-studied. Methods We aimed to study the immune responses in children with MIS in comparison to children with acute COVID-19 and children with other infections. Whole blood was stimulated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)–specific antigens and flow cytometry was performed to examine CD4+ and CD8+ T-cell responses. Results Children with MIS had higher frequencies of CD4+ and CD8+ T cells expressing cytokines at baseline and upon SARS-CoV-2 antigen–specific stimulation in comparison to children with COVID-19 and/or other infections. Children with COVID-19 also exhibited higher frequencies of CD4+ and CD8+ T cells expressing cytokines at baseline and upon SARS-CoV-2 antigen–specific stimulation in comparison to children with other infections. At 6–9 months following treatment and recovery, this enhanced response against SARS-CoV-2 antigens was down modulated in children with MIS. Conclusion Our study, therefore, provides evidence of enhanced activation of CD4+ and CD8+ T-cell responses in children with MIS and reversal following recovery.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2023) conducted an observational in Multisystem inflammatory syndrome in children (MIS-C) (n=35). Multisystem inflammatory syndrome in children (MIS-C) vs. Acute COVID-19 and other infectious diseases was evaluated on Frequencies of CD4+ and CD8+ T cells expressing cytokines (IFN-γ, IL-2, TNF-α, IL-17A) at baseline and upon SARS-CoV-2 antigen-specific stimulation. Children with MIS-C had significantly higher frequencies of CD4+ and CD8+ T cells expressing cytokines at baseline and upon SARS-CoV-2 antigen stimulation compared to those with COVID-19 or other infections, which reversed 6-9 months post-recovery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: